XML 17 R11.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements

3. Fair Value Measurements

Assets Measured at Fair Value on a Recurring Basis

The following table presents our financial assets measured at fair value on a recurring basis by level within the fair value hierarchy for the periods indicated (in thousands):

 

 

 

 

March 31, 2025

 

 

 

Valuation

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

 

 

Hierarchy

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

Level 1

 

$

9,301

 

 

$

 

 

$

 

 

$

9,301

 

Commercial paper

 

Level 2

 

 

101,313

 

 

 

 

 

 

(28

)

 

 

101,285

 

U.S. government bonds

 

Level 2

 

 

178,916

 

 

 

347

 

 

 

(15

)

 

 

179,248

 

Agency bonds

 

Level 2

 

 

52,517

 

 

 

68

 

 

 

(2

)

 

 

52,583

 

Corporate debt securities

 

Level 2

 

 

8,331

 

 

 

12

 

 

 

(3

)

 

 

8,340

 

U.S. Treasury securities

 

Level 2

 

 

45,551

 

 

 

2

 

 

 

(2

)

 

 

45,551

 

Agency discount securities

 

Level 2

 

 

5,784

 

 

 

 

 

 

 

 

 

5,784

 

Total cash equivalents and marketable securities

 

 

 

$

401,713

 

 

$

429

 

 

$

(50

)

 

$

402,092

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

$

78,708

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

323,384

 

Total cash equivalents and marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

$

402,092

 

 

 

 

 

 

December 31, 2024

 

 

 

Valuation

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

 

 

Hierarchy

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

Level 1

 

$

22,645

 

 

$

 

 

$

 

 

$

22,645

 

Commercial paper

 

Level 2

 

 

51,982

 

 

 

14

 

 

 

(5

)

 

 

51,991

 

U.S. government bonds

 

Level 2

 

 

169,860

 

 

 

439

 

 

 

(29

)

 

 

170,270

 

Agency bonds

 

Level 2

 

 

63,753

 

 

 

111

 

 

 

(5

)

 

 

63,859

 

Corporate debt securities

 

Level 2

 

 

6,154

 

 

 

15

 

 

 

(3

)

 

 

6,166

 

U.S. Treasury securities

 

Level 2

 

 

44,499

 

 

 

10

 

 

 

 

 

 

44,509

 

Agency discount securities

 

Level 2

 

 

18,940

 

 

 

2

 

 

 

 

 

 

18,942

 

Total cash equivalents and marketable securities

 

 

 

$

377,833

 

 

$

591

 

 

$

(42

)

 

$

378,382

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

$

64,487

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

313,895

 

Total cash equivalents and marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

$

378,382

 

The valuation techniques used to measure the fair values of our Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices when available. If quoted market prices are not available, the fair value for the security is estimated under the market or income approach using pricing models with market observable inputs.

The following table summarizes the estimated fair value of investments in marketable securities by effective contractual maturity dates as of March 31, 2025 (in thousands):

Within one year

 

$

369,008

 

After one year through two years

 

 

33,084

 

Total cash equivalents and marketable securities

 

$

402,092

 

 

As of March 31, 2025, marketable securities in an unrealized loss position include primarily fixed-rate debt securities of varying maturities, which are sensitive to changes in the yield curve and other market conditions. All of the fixed-rate debt securities in a loss position are investment-grade debt securities. We have the intent and ability to hold such securities until recovery of the unrealized losses. Based on our evaluation, the unrealized losses as of March 31, 2025 were insignificant and did not reflect increased credit risks within specific securities holdings. No allowance for credit losses was recorded as of March 31, 2025 and December 31, 2024.

Liabilities Measured at Fair Value on a Recurring Basis

Warrant Liability

As of March 31, 2025, our only financial liability measured at fair value on a recurring basis relates to warrants to purchase up to 311,996 shares of our common stock issued in connection with the Term Loan Facility (see Note 6). The number of warrants that become exercisable is contingent on subsequent loan advances drawn by us under the Term Loan Facility. As such, the warrants are not considered to be indexed to our own stock and were accounted for as a liability. We recorded the fair value of the warrants upon issuance using a probability-weighted scenario analysis with a Black-Scholes option-pricing model. We are required to revalue the warrants at each reporting date with any changes in fair value recorded on the consolidated statements of operations and comprehensive loss until the exercise contingencies are resolved. The valuation of the warrants is considered under Level 3 of the fair value hierarchy, taking into account the likelihood of the warrants becoming exercisable in addition to assumptions used in the Black-Scholes option-pricing model.

The reconciliation of our warrant liability measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows (in thousands):

 

 

Warrant Liability

 

Balance outstanding as of December 31, 2024

 

$

516

 

Change in fair value

 

 

(221

)

Balance outstanding as of March 31, 2025

 

$

295

 

 

The warrants had a fair value of $0.3 million as of March 31, 2025, based on a Black-Scholes valuation with the following assumptions: risk-free interest rate of 4.2%, no dividends, expected volatility of 87.8% and expected term of 9.5 years.